A major discovery in cancer investigation is arising with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor inhibitor protein is frequently disabled in various types of malignancies, https://socialeweb.com/story7448865/nanobodies-restore-the-p53-protein-new-potential-pathway-for-malignant-therapy